Andrew R. Hoffman
Publications
- Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007; (2): 104-15
- CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science. 2006; (5771): 269-72
- A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest. 2003; (2): 265-73
- Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet. 1997; (1): 12-3
- Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature. 1994; (6499): 714-7
- Successful long-term treatment of Cushing disease with mifepristone (RU486). Endocr Pract. 2012 Sep-Oct; (5): e114-20
- Long-term surveillance of growth hormone therapy. J Clin Endocrinol Metab. 2012; (1): 68-72
- Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab. 2012; (3): 862-70
- Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab. 2011; (12): 3855-63
- IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology. 2011; (9): 3332-42
- Mortality risk in older men associated with changes in weight, lean mass, and fat mass. J Am Geriatr Soc. 2011; (2): 233-40
- Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum Mol Genet. 2010; (5): 901-19
- A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele. Mol Endocrinol. 2008; (6): 1476-88
- CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop. Mol Cell Biol. 2008; (20): 6473-82
- Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008; (10): 747-58
- Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab. 2005; (12): 6431-40
- Activating and silencing histone modifications form independent allelic switch regions in the imprinted Gnas gene. Hum Mol Genet. 2004; (7): 741-50
- Promoter-restricted histone code, not the differentially methylated DNA regions or antisense transcripts, marks the imprinting status of IGF2R in human and mouse. Hum Mol Genet. 2004; (19): 2233-45
- An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoa. J Biol Chem. 2002; (16): 13518-27
- One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab. 2001; (4): 1496-503
Help
Trial Administration